Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
126
NCT02050958
Pilot Study of OXP001 and Brufen in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2014
Completion: Apr 30, 2014
NCT02351024
Phase I Study PK Study With OXP005 and Naprosyn
Start: Feb 28, 2015
Completion: Mar 31, 2015
NCT02408978
Pilot Study of OXP005 to Assess Gastroduodenal Irritation
Start: May 31, 2015
Completion: Jun 30, 2015
NCT02521207
Pilot Study of OXP001(2) and Brufen in Healthy Subjects
Start: Jul 31, 2015
Completion: Sep 30, 2015
NCT02974361
Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen
Start: Dec 31, 2016
Completion: May 3, 2017